Press Releases

ASX Announcement

By |2021-03-17T23:54:19+00:00March 17th, 2021|

Investor Presentation

Download PDF

ASX Announcement

By |2021-03-17T23:50:50+00:00March 17th, 2021|

Successful Completion of Dosing in First Patient Cohort

Download PDF

ASX Announcement

By |2021-02-24T01:21:57+00:00February 24th, 2021|

Dr Eliot Bourk, Former Kite Pharma Senior Executive, Joins Chimeric as VP Business & Corporate Development

Download PDF

Shareholder newsletter

By |2021-02-08T01:19:46+00:00February 8th, 2021|

January 2021 newsletter

Download PDF

ASX Announcement

By |2021-02-01T02:18:14+00:00February 1st, 2021|

Former Juno Executive Cindy Elkins Joins Chimeric Board

Download PDF

ASX Announcement

By |2021-01-18T04:54:04+00:00January 18th, 2021|

Chimeric Therapeutics Commences Trading on the ASX

Download PDF

Media release

By |2020-11-26T01:16:30+00:00November 26th, 2020|

Senior CAR T Executives Join Chimeric Leadership Team

Download PDF

Media release

By |2020-09-28T02:32:05+00:00September 28th, 2020|

Dr Nader Sanai & Dr Larry Couture appointed to Scientific Advisory Board

Download PDF

Media release

By |2020-09-24T06:08:09+00:00September 24th, 2020|

Chimeric completes $4.3m seed capital raising

Download PDF

Media release

By |2020-09-24T06:05:22+00:00September 22nd, 2020|

Chimeric enters licensing agreement with City of Hope to develop CLTX CAR-T cell therapy

Download PDF